Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...

PORTOS can determine which patients with localized prostate cancer will benefit from dose-escalation of radiotherapy, data suggest.

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...

Untreated prostate cancer can sometimes cause erectile dysfunction (ED). However, ED is more commonly associated with ...

External beam radiation therapy with or without short-term androgen deprivation showed 15-year survival benefits for ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

Radiotherapy, a standard of care treatment for localized prostate cancer includes, has shown remarkable success. This ...

By comparison, prostate cancer figures are somewhat better, with about one-third of patients surviving beyond two years. Elsewhere in the world, these figures are nearly 100 per cent for prostate ...